Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.

Saved in:
Bibliographic Details
Title: Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Authors: Iacoboni G; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Iraola-Truchuelo J; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., O'Reilly M; Department of Hematology University College London Hospitals London UK., Navarro V; Oncology Data Science (ODySey) Group Vall d´Hebron Institute of Oncology (VHIO) Barcelona Spain., Menne T; Department of Hematology Freeman Hospital Newcastle UK., Kwon M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain., Martín-López AÁ; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain., Chaganti S; Department of Hematology Queen Elizabeth Hospital Birmingham UK., Delgado J; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain., Roddie C; Department of Hematology University College London Hospitals London UK., Pérez A; Haematology Department, Hospital Clínico Universitario INCLIVA Research Institute Valencia Spain., Norman J; Department of Hematology Manchester Royal Infirmary Manchester UK., Guerreiro M; Haematology Department Hospital Universitario La Fe Valencia Spain., Gibb A; Department of Hematology The Christie Hospital Manchester UK., Caballero AC; Hematology Department Hospital Universitario Sant Pau Barcelona Spain., Besley C; Department of Hematology University Hospitals Bristol and Weston Bristol UK., Martínez-Cibrián N; Hematology Department Hospital Clínic Barcelona Spain., Mussetti A; Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, IDIBELL Universitat de Barcelona Barcelona Spain., Sanderson R; Department of Hematology King's College Hospital London UK., Luzardo H; Department of Hematology Hospital Universitario de Gran Canaria Doctor Negrín Islas Canarias Spain., Iyengar S; Department of Hematology Royal Marsden Hospital London UK., Sánchez JM; Department of Hematology Hospital Universitario 12 de octubre Madrid Spain., Jones C; Department of Hematology University Hospital of Wales Cardiff UK., Sancho JM; Hematology Department ICO-IJC Hospital Germans Trias i Pujol Barcelona Spain., Barba P; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Latif AL; Department of Hematology Queen Elizabeth II Hospital Glasgow UK., López-Corral L; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain., Hernani R; Haematology Department, Hospital Clínico Universitario INCLIVA Research Institute Valencia Spain., Reguera JL; Hematology Department, Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC Universidad de Sevilla Sevilla Spain., Sureda A; Hematology Department, Institut Catala d'Oncologia, Hospital Duran i Reynals, L'Hospitalet De Llobregat, IDIBELL Universitat de Barcelona Barcelona Spain., Garcia-Sancho AM; Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC University of Salamanca Salamanca Spain., Bastos M; Department of Hematology Hospital General Universitario Gregorio Marañón Madrid Spain., Abrisqueta P; Department of Hematology University Hospital Vall d'Hebron Barcelona Spain.; Experimental Hematology Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain., Kuhnl A; Department of Hematology King's College Hospital London UK.
Source: HemaSphere [Hemasphere] 2024 May 21; Vol. 8 (5), pp. e62. Date of Electronic Publication: 2024 May 21 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2572-9241
DOI:10.1002/hem3.62